by Usha Govindarajulu | Nov 25, 2020 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
After most of the United States was enjoying somewhat of a break in COVID-19 surges and closures in the latter part of the summer, COVID-19, which still roams freely, has led into a second resurgence in almost every state in the latter fall and is leading to potential...
by Usha Govindarajulu | Nov 12, 2020 | Blog, Epidemiology, Healtcare, Usha Govindarajulu
The White House has been following a contestable strategy related to controlling the coronavirus called the Great Barrington Declaration. In this declaration created by Jay Bhattacharya, Sunetra Gupta, and Martin Kulldorff, who are all academics, they advocate for...
by Usha Govindarajulu | Oct 29, 2020 | Epidemiology, Healtcare, Usha Govindarajulu
Recently, the FDA deemed Remdesivir as a treatment for COVID-19, the first treatment approved as such. Back on May 1, they had granted EUA, emergency use authorization, of Remdesivir for COVID-19 and many hospitals made use of it, especially given that there was very...
by Usha Govindarajulu | Oct 13, 2020 | Healtcare, New York, Usha Govindarajulu
In the last several weeks, though New Yorkers have been enjoying things slowly reopening and having a little more freedom to go out and about and enjoy outdoor dining with indoor dining around the corner and gyms reopened, cases slowly started rising again. At...
by Usha Govindarajulu | Sep 29, 2020 | Epidemiology, Healtcare, Professor
What makes someone have lasting immunity to COVID-19? This is a burning question in order to understand how to protect against the virus and sustain immunity. This also has implications for the various vaccines that are either in development or in testing phases. ...
